Rani Therapeutics grants CFO Nicholas Maestas option for 2 million shares at $0.7 exercise price

Reuters2026/07/20 20:05

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Rani Therapeutics granted CFO Nicholas Maestas a stock option for 2 million Class A shares on July 17, 2026.
Exercise price set at USD 0.7 per share; option term runs 10 years.
Award vests over four years, with 25% vesting after one year; remainder vests monthly over the next 36 months.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rani Therapeutics Holdings Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607201605PRIMZONEFULLFEED9764512) on July 20, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Rani Therapeutics grants CFO Nicholas Maestas option for 2 million shares at $0.7 exercise price

You may also like

Crypto prices